CIK 0001600620 · Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981231763
- Phone
- 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- S-8 Other Securities Offered to Employees in Benefit Plans
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- DEFA14A Proxy Proxy Materials
Page 1 of 4 · 74 filings